Molecular Pathology — MCQs
On this page
Foci of granulomatous inflammation show all of the following except?
NKX3-1 immunohistochemistry is used for the diagnosis of which of the following?
Which of the following is considered a major pyrogenic cytokine?
A 60-year-old asymptomatic female shows the following change in the tunica media of blood vessels. What is the diagnosis?
What is the primary molecular pathology associated with Marfan syndrome?
What is the characteristic feature of apoptosis on light microscopy?
Calnexin and calreticulin are primarily classified as which of the following?
Blau syndrome is associated with a mutation in which gene?
A study of peripheral blood smears shows that neutrophil nuclei of women have a Barr body, whereas those of men do not. The Barr body is an inactivated X chromosome. Which of the following forms of RNA is most likely to play a role in Barr body formation?
Which of the following enzymes is NOT responsible for the removal of free radicals?
Molecular Pathology Indian Medical PG Practice Questions and MCQs
Question 1: Foci of granulomatous inflammation show all of the following except?
- A. Eosinophils (Correct Answer)
- B. Epithelioid cells
- C. Fibrosis
- D. Lymphocytes
Explanation: ### Explanation A **granuloma** is a distinctive pattern of chronic inflammation characterized by a focal collection of activated macrophages, often surrounded by a rim of lymphocytes and sometimes a peripheral zone of fibrosis [1]. **Why Eosinophils (Option A) is the correct answer:** Eosinophils are typically associated with **Type I hypersensitivity reactions** (allergic diseases) or **parasitic infections** [2]. While they may occasionally be seen in specific types of granulomatous diseases (like Churg-Strauss syndrome or certain fungal infections), they are **not** a defining or universal component of the classic granulomatous inflammatory focus. **Analysis of Incorrect Options:** * **Epithelioid cells (Option B):** These are the hallmark of granulomas. They are activated macrophages that have developed abundant pink cytoplasm, resembling epithelial cells [1]. They are induced by IFN-γ secreted by T-cells. * **Fibrosis (Option C):** In older granulomas, a rim of fibroblasts and connective tissue (fibrosis) often develops due to the secretion of growth factors like TGF-β [1]. This is the body’s attempt to "wall off" the offending agent. * **Lymphocytes (Option D):** Granulomatous inflammation is a form of **Type IV (delayed-type) hypersensitivity**. T-lymphocytes (specifically CD4+ Th1 cells) are essential for activating macrophages into epithelioid cells via cytokine signaling [1]. **NEET-PG High-Yield Pearls:** * **The "Signature" Cell:** The epithelioid cell is the diagnostic cell of a granuloma. * **Giant Cells:** Formed by the fusion of epithelioid cells [1]. Examples include **Langhans giant cells** (peripheral nuclei; seen in TB) and **Foreign body giant cells** (disorganized nuclei). * **Caseation:** Central "cheese-like" necrosis is highly suggestive of *Mycobacterium tuberculosis*. * **Non-caseating granulomas:** Classically seen in Sarcoidosis, Crohn’s disease, and Berylliosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, pp. 107-109. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 195-196.
Question 2: NKX3-1 immunohistochemistry is used for the diagnosis of which of the following?
- A. Colorectal carcinoma
- B. Pancreatic carcinoma
- C. Prostate carcinoma (Correct Answer)
- D. Renal cell carcinoma
Explanation: **Explanation:** **NKX3.1** is a prostate-specific androgen-regulated homeobox gene located on chromosome 8p21. It plays a critical role in normal prostate development and the differentiation of prostatic epithelial cells. 1. **Why Prostate Carcinoma is Correct:** NKX3.1 is currently considered one of the most sensitive and specific immunohistochemical (IHC) markers for **Prostatic Adenocarcinoma**. Its primary clinical utility lies in identifying the prostatic origin of a metastatic tumor, especially when the tumor is high-grade or poorly differentiated [1]. While PSA (Prostate-Specific Antigen) and PSAP (Prostate-Specific Acid Phosphatase) are traditional markers, NKX3.1 often maintains expression in cases where PSA might be focal or negative. 2. **Why Other Options are Incorrect:** * **Colorectal Carcinoma:** The characteristic IHC profile includes **CDX2**, CK20 (+), and CK7 (-). * **Pancreatic Carcinoma:** Typically expresses **CA19-9**, CK7, and CK19. * **Renal Cell Carcinoma (RCC):** The most specific markers for RCC are **PAX8** and **RCC antigen** (CD10 is also frequently positive). **High-Yield Clinical Pearls for NEET-PG:** * **Sensitivity:** NKX3.1 is highly sensitive (>95%) for both primary and metastatic prostate cancer. * **Nuclear Staining:** Unlike PSA (which is cytoplasmic), NKX3.1 shows a distinct **nuclear staining** pattern, making it easier to interpret in small biopsies. * **Differential Diagnosis:** In the context of a "Small Round Blue Cell Tumor" in the testis/prostate region, NKX3.1 helps distinguish prostate alveolar rhabdomyosarcoma (negative) from metastatic prostate cancer (positive). * **Loss of Expression:** Deletion of the 8p21 locus (where NKX3.1 resides) is one of the earliest genetic events in prostate carcinogenesis, often associated with the transition from PIN (Prostatic Intraepithelial Neoplasia) to invasive cancer [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 988-994.
Question 3: Which of the following is considered a major pyrogenic cytokine?
- A. Interferon alpha
- B. Tumor necrosis factor beta
- C. Interleukin-3
- D. Interleukin-1 (Correct Answer)
Explanation: ### Explanation **Correct Answer: D. Interleukin-1** **Mechanism of Action:** Fever (pyrexia) is mediated by **pyrogens**. Interleukin-1 (IL-1) is a potent **endogenous pyrogen** produced primarily by activated macrophages. When IL-1 is released into the circulation, it travels to the anterior hypothalamus (the body’s thermostat). Here, it induces the synthesis of **Prostaglandin E2 (PGE2)** by stimulating the enzyme cyclooxygenase (COX) [1]. PGE2 then acts on the hypothalamic thermoregulatory center to increase the "set-point" for body temperature, resulting in fever [1]. **Analysis of Incorrect Options:** * **A. Interferon alpha (IFN-̑):** Primarily involved in antiviral responses and the activation of Natural Killer (NK) cells. While high doses can cause flu-like symptoms, it is not a primary pyrogenic cytokine. * **B. Tumor necrosis factor beta (TNF-̲):** Also known as Lymphotoxin, it is involved in lymphoid organ development and cytotoxic responses, but it is not a major mediator of the systemic inflammatory febrile response. * **C. Interleukin-3 (IL-3):** Acts as a colony-stimulating factor (CSF) [1] that supports the growth and differentiation of hematopoietic stem cells in the bone marrow. It has no role in thermoregulation. **High-Yield Clinical Pearls for NEET-PG:** * **Major Endogenous Pyrogens:** The "Big Three" are **IL-1, TNF-̰, and IL-6** [1]. Among these, IL-1 is often cited as the most potent. * **Exogenous Pyrogens:** The most common example is **Lipopolysaccharide (LPS)**, an endotoxin found in the cell wall of Gram-negative bacteria. LPS stimulates macrophages to release IL-1 and TNF. * **Pharmacology Link:** Antipyretics like **Aspirin and Paracetamol** reduce fever by inhibiting the COX enzyme, thereby blocking the synthesis of PGE2 in the hypothalamus [1]. * **Acute Phase Response:** IL-1, IL-6, and TNF-̰ also stimulate the liver to produce acute-phase proteins like C-reactive protein (CRP) and Fibrinogen [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Inflammation and Repair, p. 111.
Question 4: A 60-year-old asymptomatic female shows the following change in the tunica media of blood vessels. What is the diagnosis?
- A. Medial calcification (Correct Answer)
- B. Medial fibrosis
- C. Amyloidosis
- D. None of the above
Explanation: ***Medial calcification*** - **Mönckeberg's medial calcific sclerosis** presents as **calcium deposits** in the tunica media, appearing as **basophilic deposits** on H&E staining in elderly patients. - This condition is typically **asymptomatic** and does **not narrow the vessel lumen**, distinguishing it from intimal calcification seen in atherosclerosis. *Medial fibrosis* - Would show **collagen deposition** and **fibroblast proliferation** in the tunica media rather than calcium deposits. - Typically associated with **hypertensive vascular disease** and would appear **eosinophilic** on H&E staining, not basophilic. *Amyloidosis* - Characterized by **Congo red positive** deposits that show **apple-green birefringence** under polarized light. - **Amyloid deposits** would appear as **homogeneous eosinophilic material** on routine H&E staining, not calcium deposits. *None of the above* - The clinical presentation of an **asymptomatic elderly female** with tunica media changes is classic for **Mönckeberg's sclerosis**. - The **basophilic calcium deposits** in the media are pathognomonic for medial calcification, making this the correct diagnosis.
Question 5: What is the primary molecular pathology associated with Marfan syndrome?
- A. Fibrillin I (Correct Answer)
- B. Fibrillin II
- C. Collagen
- D. Elastin
Explanation: **Explanation:** **Marfan Syndrome** is an autosomal dominant disorder of connective tissue caused by mutations in the **FBN1 gene** located on chromosome **15q21**. This gene encodes **Fibrillin-1**, a glycoprotein that serves as the major structural component of extracellular microfibrils [1]. These microfibrils provide a scaffold for the deposition of elastin and are essential for the integrity of tissues such as the aortic wall, skeletal system, and the suspensory ligaments of the lens [1]. * **Why Fibrillin-1 is correct:** Fibrillin-1 not only provides structural support but also regulates **TGF-̢ signaling** [2]. A deficiency in Fibrillin-1 leads to excessive TGF-̢ activation, causing abnormal vascular remodeling and bone overgrowth [2]. * **Why Fibrillin-2 is incorrect:** Mutations in Fibrillin-2 (FBN2 gene on chromosome 5) cause **Congenital Contractural Arachnodactyly (Beals Syndrome)**, characterized by "crumpled" ears and joint contractures, but without the life-threatening aortic complications of Marfan. * **Why Collagen is incorrect:** Collagen defects are primarily associated with **Ehlers-Danlos Syndrome (EDS)** or Osteogenesis Imperfecta [3]. * **Why Elastin is incorrect:** While elastin is associated with fibrillin in elastic fibers [1], primary elastin mutations are linked to **Williams Syndrome** or Cutis Laxa. **High-Yield Clinical Pearls for NEET-PG:** 1. **Cardiovascular:** Aortic root dilation and **dissecting aneurysm** (most common cause of death) and Mitral Valve Prolapse (MVP) [2]. 2. **Ocular:** **Ectopia lentis** (typically **upward** and outward subluxation). 3. **Skeletal:** Arachnodactyly, pectus excavatum, and a high-arched palate [2]. 4. **Diagnostic Sign:** Positive **Walker-Murdoch sign** (wrist sign) and **Steinberg sign** (thumb sign). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 35-36. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 153-154. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 154-155.
Question 6: What is the characteristic feature of apoptosis on light microscopy?
- A. Cellular swelling
- B. Nuclear compaction (Correct Answer)
- C. Intact cell membrane
- D. Cytoplasmic eosinophilia
Explanation: **Explanation:** **Apoptosis**, or programmed cell death, is a highly regulated process characterized by specific morphological changes [1]. The hallmark feature on light microscopy is **Nuclear Compaction (Pyknosis)**. This occurs due to chromatin condensation, where the chromatin aggregates peripherally under the nuclear membrane into dense masses. This is followed by **karyorrhexis** (nuclear fragmentation), leading to the formation of apoptotic bodies. **Analysis of Options:** * **A. Cellular Swelling:** This is a hallmark of **Necrosis** (oncosis) [3]. In apoptosis, the cell actually **shrinks** (cytoplasmic shrinkage) due to the condensation of organelles. * **C. Intact Cell Membrane:** While it is true that the cell membrane remains structurally intact during apoptosis (preventing inflammation), this is a **structural** feature rather than the most "characteristic" diagnostic feature seen on light microscopy compared to the distinct nuclear changes. * **D. Cytoplasmic Eosinophilia:** While apoptotic cells do show increased eosinophilia (due to loss of cytoplasmic RNA and protein denaturation), this is a non-specific finding also seen prominently in **Necrosis**. **High-Yield NEET-PG Pearls:** * **Gold Standard for Detection:** The **TUNEL assay** (Terminal deoxynucleotidyl transferase dUTP nick end labeling) is used to detect the characteristic DNA fragmentation (internucleosomal cleavage). * **Electrophoresis Pattern:** Apoptosis shows a **"Step-ladder pattern"** (due to 180-200 bp fragments), whereas Necrosis shows a **"Smear pattern."** * **Key Enzyme:** **Caspases** (Cysteine-aspartic proteases) are the executioners of apoptosis [2]. * **Membrane Marker:** **Annexin V** is used to identify apoptotic cells as it binds to Phosphatidylserine, which flips to the outer leaflet of the membrane. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 63-64. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 64-65. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 51-53.
Question 7: Calnexin and calreticulin are primarily classified as which of the following?
- A. Glycoproteins
- B. Chaperones (Correct Answer)
- C. Tumor markers
- D. Enzymes
Explanation: **Explanation:** **1. Why Chaperones is the Correct Answer:** Calnexin and calreticulin are specialized **molecular chaperones** located within the lumen of the Endoplasmic Reticulum (ER). Their primary function is "quality control" during protein synthesis [1]. They specifically bind to misfolded or partially folded glycoproteins, ensuring they achieve their correct three-dimensional conformation before being transported to the Golgi apparatus [1]. If a protein remains misfolded despite their intervention, it is targeted for degradation (ER-associated degradation or ERAD). **2. Analysis of Incorrect Options:** * **A. Glycoproteins:** While calnexin and calreticulin *interact* with glycoproteins (specifically those with monoglucosylated glycans), they are defined by their functional role as chaperones rather than being classified primarily as glycoproteins themselves. * **C. Tumor markers:** These are substances found in blood or tissue that indicate the presence of cancer (e.g., CEA, AFP). Calnexin and calreticulin are ubiquitous intracellular proteins and are not used as diagnostic tumor markers. * **D. Enzymes:** While they have binding affinities, they do not catalyze biochemical reactions in the way classical enzymes (like kinases or dehydrogenases) do. **3. High-Yield Clinical Pearls for NEET-PG:** * **Location Difference:** Calnexin is a **membrane-bound** ER protein, whereas calreticulin is a **soluble** luminal protein. * **Calcium Binding:** Both proteins are calcium-binding; calreticulin is the major calcium-sequestering protein in the ER. * **ER Stress:** Accumulation of misfolded proteins leads to "ER Stress," triggering the **Unfolded Protein Response (UPR)**, which can lead to apoptosis if unresolved [1]. * **Clinical Link:** Mutations in the *CALR* (calreticulin) gene are high-yield markers for **Myeloproliferative Neoplasms (MPN)**, specifically Essential Thrombocythemia and Primary Myelofibrosis (JAK2-negative cases). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 25-26.
Question 8: Blau syndrome is associated with a mutation in which gene?
- A. NOD2/CARD15 (Correct Answer)
- B. NOD1/CARD1
- C. NOD2/CARD10
- D. NOD3/CARD12
Explanation: **Explanation:** **Blau Syndrome** is a rare, autosomal dominant autoinflammatory disorder characterized by the clinical triad of **granulomatous dermatitis, uveitis, and symmetric arthritis**. **1. Why Option A is Correct:** The disease is caused by a gain-of-function mutation in the **NOD2 gene** (also known as **CARD15**), located on chromosome 16. The NOD2 protein acts as an intracellular pattern recognition receptor (PRR) that senses muramyl dipeptide (a component of bacterial peptidoglycan). In Blau syndrome, the mutation leads to constitutive activation of the NF-κB pathway, resulting in inappropriate pro-inflammatory signaling and the formation of non-caseating granulomas. **2. Why Other Options are Incorrect:** * **NOD1/CARD1:** While also an intracellular PRR, it recognizes different bacterial ligands (D-glutamyl-meso-diaminopimelic acid) and is not associated with Blau syndrome. * **NOD2/CARD10:** This is a distractor; CARD10 (CARMA3) is involved in GPCR-mediated NF-κB activation but is not the gene for Blau syndrome. * **NOD3/CARD12:** Also known as NLRC4, mutations here are associated with "NLRC4-MAS" (Macrophage Activation Syndrome) and familial cold autoinflammatory syndrome, not Blau syndrome. **3. High-Yield Clinical Pearls for NEET-PG:** * **Genetics:** Blau syndrome is the **familial** form of early-onset sarcoidosis. If the same mutation occurs *de novo* (sporadically), it is referred to as **Early-Onset Sarcoidosis (EOS)**. * **Pathology:** Characterized by **non-caseating granulomas** in the skin, joints, and eyes. * **Differential Diagnosis:** Unlike systemic sarcoidosis, Blau syndrome typically **spares the lungs**. * **NOD2 & Crohn’s Disease:** Interestingly, while *gain-of-function* mutations in NOD2 cause Blau syndrome, *loss-of-function* (polymorphisms) in the same gene are strongly associated with **Crohn’s disease** [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 223-224.
Question 9: A study of peripheral blood smears shows that neutrophil nuclei of women have a Barr body, whereas those of men do not. The Barr body is an inactivated X chromosome. Which of the following forms of RNA is most likely to play a role in Barr body formation?
- A. lncRNA (Correct Answer)
- B. mRNA
- C. miRNA
- D. siRNA
Explanation: **Explanation:** The correct answer is **lncRNA (Long non-coding RNA)**. **1. Why lncRNA is correct:** The Barr body represents an inactivated X chromosome (Lyonization), a process essential for dosage compensation in females. This inactivation is mediated by the **XIST gene** (*X-inactive specific transcript*), located in the X-inactivation center (XIC). The XIST gene produces a unique type of RNA that does not code for proteins; instead, it is a **long non-coding RNA (lncRNA)** [1]. XIST lncRNA "coats" the X chromosome from which it is transcribed, triggering gene silencing through chromatin remodeling and DNA methylation, resulting in the formation of heterochromatin (the Barr body) [1]. **2. Why other options are incorrect:** * **mRNA (Messenger RNA):** These are coding RNAs that serve as templates for protein synthesis. * **miRNA (microRNA):** These are small (approx. 22 nucleotides) non-coding RNAs that typically regulate gene expression post-transcriptionally by causing mRNA degradation or inhibiting translation [2]. * **siRNA (Small interfering RNA):** These are double-stranded RNAs involved in the RNA interference (RNAi) pathway, primarily acting to silence specific target genes by mRNA cleavage. **Clinical Pearls for NEET-PG:** * **Formula for Barr Bodies:** Number of Barr bodies = (Total X chromosomes - 1). * *Turner Syndrome (45,XO):* 0 Barr bodies [1]. * *Klinefelter Syndrome (47,XXY):* 1 Barr body. * **Morphology:** In neutrophils, the Barr body appears as a **"Drumstick"** appendage on the nucleus. * **XIST vs. TSIX:** While XIST promotes inactivation, its antisense transcript **TSIX** prevents inactivation on the active X chromosome. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, pp. 173-174. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 16-17.
Question 10: Which of the following enzymes is NOT responsible for the removal of free radicals?
- A. Catalase
- B. Superoxide Dismutase
- C. NADPH oxidase (Correct Answer)
- D. Glutathione peroxidase
Explanation: ### Explanation The core concept here is the distinction between **Antioxidant Enzymes** (which scavenge/remove free radicals) and **Pro-oxidant Enzymes** (which generate free radicals) [1]. **Why NADPH Oxidase is the Correct Answer:** Unlike the other options, **NADPH oxidase** is a pro-oxidant enzyme. It is primarily located in the membranes of phagosomes in neutrophils and macrophages [1]. Its physiological role is the **generation** of the superoxide radical ($O_2^{\bullet-}$) from molecular oxygen during the "Respiratory Burst." This process is essential for the oxygen-dependent killing of ingested microorganisms [2]. **Analysis of Incorrect Options (Antioxidant Enzymes):** * **Superoxide Dismutase (SOD):** Converts the superoxide radical ($O_2^{\bullet-}$) into hydrogen peroxide ($H_2O_2$). It acts as the first line of defense against superoxide [1], [2]. * **Catalase:** Located in peroxisomes, it decomposes $H_2O_2$ into water and oxygen ($2H_2O_2 \rightarrow 2H_2O + O_2$) [1]. * **Glutathione Peroxidase:** Found in the cytoplasm, it neutralizes $H_2O_2$ and lipid peroxides by using reduced glutathione (GSH) as a cofactor, converting it to oxidized glutathione (GSSG) [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Chronic Granulomatous Disease (CGD):** Caused by a genetic deficiency in **NADPH oxidase**. Patients cannot produce superoxide radicals, leading to recurrent infections with catalase-positive organisms (e.g., *S. aureus*, *Aspergillus*). * **Fenton Reaction:** The process where $Fe^{2+}$ reacts with $H_2O_2$ to produce the highly reactive **Hydroxyl radical** ($\bullet OH$), which is the most damaging free radical in biological systems [1]. * **Glutathione Reductase:** This enzyme regenerates GSH from GSSG using NADPH as a cofactor (sourced from the HMP shunt). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, pp. 59-60. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 100-101.
Practice by Chapter
Principles of Molecular Pathology
Practice Questions
DNA and RNA Analysis Techniques
Practice Questions
Cytogenetics
Practice Questions
Polymerase Chain Reaction Applications
Practice Questions
Next-Generation Sequencing
Practice Questions
Molecular Diagnosis of Infectious Diseases
Practice Questions
Molecular Oncology
Practice Questions
Pharmacogenomics
Practice Questions
Genetic Counseling and Risk Assessment
Practice Questions
Molecular Diagnostics Quality Control
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free